PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Nov-2023 Odyssey Therapeutics to Present Data for Three Immunology Programs at American College of Rheumatology Convergence 2023 Businesswire
09-Nov-2023 Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China Businesswire
09-Nov-2023 Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update Businesswire
09-Nov-2023 GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference Businesswire
09-Nov-2023 Antibe Reports PK Results of First Clinical Study of Otenaproxesul’s New Formulation Businesswire
09-Nov-2023 Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - ResearchAndMarkets.com Businesswire
09-Nov-2023 Stevanato Group to Present at the Jefferies London Healthcare Conference Businesswire
09-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Nov-2023 Biodesix to Participate in Two Upcoming Investor Conferences in November Businesswire
09-Nov-2023 LuxCreo Bolsters Dental Innovation With New Executive Advisor and Dental Advisory Board Formation Businesswire
09-Nov-2023 CERBA HEALTHCARE FAIT EVOLUER SA GOUVERNANCE ET NOMME EMMANUEL LIGNER PRESIDENT DU GROUPE Businesswire
09-Nov-2023 Cerba HealthCare Changes Its Governance and Appoints Emmanuel Ligner Group Chief Executive Officer Businesswire
09-Nov-2023 Hytera Launches New Generation of Intrinsically Safe Two-way Radios for Enhanced Personnel Safety and Communication Efficiency Businesswire
09-Nov-2023 Almirall’s Nine-month 2023 Results: Businesswire
09-Nov-2023 Celyad Oncology reports third quarter 2023 financial results and recent business highlights Businesswire
09-Nov-2023 Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer Businesswire
09-Nov-2023 Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis Businesswire
09-Nov-2023 I-Tek Medical and Vita Group Join Forces to Create VitaTek: The Only Vertically Integrated Medical Device Company Businesswire
09-Nov-2023 SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates Businesswire
09-Nov-2023 Kodak Reports Third-Quarter 2023 Financial Results Businesswire